drug protocol number

18620N

drug sponsor

Lundbeck

drug study

BRINTELLIX 20 mg film-coated tablet/ BRINTELLIX 10 mg film-coated tablet

drug trial site

King Abdulaziz University Hospital (Jeddah), Saudi German Hospital (Jeddah), Dr. Erfan & Bagedo General Hospital (Jeddah), University Medical Center (Riyadh), Psych care Center (Riyadh), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Al Moosa Specialized Hospital (al ahsa), King Fahad Medical City (Riyadh), Almana Hospital (Dammam), King Abdullah Medical Complex (Jeddah), Jeddah psychiatric hospital, Elite Medical Complex (Makkah)

drug status

Ongoing

drug phase